KK
Insider selling
Karthik Kuppusamy sold $1.6M of Quest Diagnostics Inc (DGX) stock
Karthik Kuppusamy, SVP, Clinical Solutions of Quest Diagnostics Inc (DGX), sold 8,147 shares of DGX stock worth $1.6M, per an SEC Form 4 filed Jun 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 4, 2026, 4 days before it was made public.
DGX has moved +19.7% since the trade date, from $196.12 to $234.76 (Sep 22, 2026 close).
- Traded
- Jun 4, 2026
- Disclosed
- Jun 8, 2026
- Filing delay
- 4 days
- Price since
- +19.7%
- Role
- SVP, Clinical Solutions
- Source
- SEC Form 4
More DGX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.